ClinicalTrials.gg
Not yet recruitingNCT07627659Updated Jun 4, 2026

Prevalence of Foot Deformities Among Adolescents in Egyptian Population

An observational study in Foot Deformities, sponsored by Assiut University. Not yet recruiting. Open to participants aged 12 Years to 18 Years. Per ClinicalTrials.gov, last updated 2026-06-04.

Sponsored by Assiut University · Observational

Study type
Observational
Model
Cohort
Time perspective
Cross-sectional
Enrollment
4,000
Ages
12 Years to 18 Years
Sex
All
01

Study summary

The aim of the study is to determine the prevalence of foot deformities among adolescents and associated factors such as age, sex, and pain. This includes identifying the types and degrees of deformities present, assessing their impact on adolescents' health, and examining how these deformities may influence daily activities

Read the detailed description

Foot deformities are common musculoskeletal conditions affecting children and adolescents worldwide, with a wide range of causes and clinical presentations. These deformities can result from congenital abnormalities, developmental changes, trauma, neuromuscular disorders, or secondary complications of systemic diseases such as diabetes and rheumatoid arthritis(1,2). Flatfoot, hallux valgus, pes cavus, and clubfoot are among the most frequently encountered types, each with distinct etiologies and clinical features Data will be collected by self-administered structured questionnaire. The aim of the study and the way of filling the questionnaire will be explained in each classroom to the students, and then he fills the questionnaire by himself.

02

Conditions studied

  • Foot Deformities

Browse trials for

03

In context

Foot Deformities

50 studies on the registry are indexed under Foot Deformities; 13 are open to participants now.

This study's planned enrollment of 4,000 is above the median of 84 across 22 observational studies indexed under Foot Deformities.

Browse Foot Deformities studies →

Lead sponsor

Assiut University is the lead sponsor of 5,078 studies on the registry; 2,178 are open to participants now.

Of its 14 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
12 Years to 18 Years
Sexes eligible
All
Sampling method
Probability sample

Study population

  • Type of the study This research will be a cross-sectional observational study designed to assess the prevalence and characteristics of foot deformities among adolescents.
  • The study will be conducted in middle and high school student

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Adolescents aged 12-18 years.
  • Willingness to participate and provide (from both the participant and guardian).
  • Ability to stand and walk without assistance for the physical examination.

Exclusion criteria

Exclusion Criteria:

  • Adolescents with a history of major lower limb surgery or amputation.
  • Those with severe neurological disorders affecting gait or foot structure (e.g., cerebral palsy, spina bifida).
  • Individuals unable to cooperate with the examination due to cognitive or psychiatric disorders.
  • Presence of acute foot trauma or infection at the time of assessment.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Observational model
Cohort
Time perspective
Cross-sectional
Enrollment
4,000 participants (estimated)
Patient registry
No

Interventions

  • OtherPrevalence of foot deformities

    Prevalence of foot deformities among adolescents in Egyptian population

06

What researchers measure

Primary outcomes

  1. Prevalence of foot deformities among adolescents in Egyptian population

    Prevalence of foot deformities among adolescents, categorized by type (e.g., flatfoot, hallux valgus, pes cavus, clubfoot).

    Time frame: Baseline

Secondary outcomes

  1. Association between foot deformities and demographic factors (age, sex).

    Correlation between foot deformities and subjective symptoms (pain, difficulty walking). Impact of foot deformities on daily activities and quality of life.

    Time frame: Baseline

07

Study locations

No study locations are listed for this record.

08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Start is estimated for Apr 2027; primary completion for Oct 2028, 18 months later.

How these figures are worked out, and which studies are left out of them.

Registered
May 31, 2026
First posted
Jun 4, 2026
StartEst.
Apr 2027
Primary completionEst.
Oct 2028
CompletionEst.
Dec 2028
Last update
Jun 4, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jun 4, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT07627659
Lead sponsor
Assiut University
Responsible party
Mohammed abdelal farrag abdelmontaleb (Doctor, Assiut University) — Principal investigator
First posted
Jun 4, 2026
Start date
Apr 2027 (estimated)
Primary completion
Oct 2028 (estimated)
Completion
Dec 2028 (estimated)
Last update
Jun 4, 2026

Study contacts

Mohammed Abdelal Farrag abdelmontaleb
Contact
mohamedabalfarag99@gmail.com
01022077898 ext. 01019522436
Amraboelfadle Elsayed Mohammed
Contact
Amr.a.mohamed@aun.edu.eg
01007788699

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in May 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion